Quick Facts

• Relief of Pain: Used for the temporary management of minor aches and discomfort.
• Headache Management: Utilized to help alleviate pain associated with various types of headaches, including migraine and tension-type headaches.
• Symptomatic Relief: Employed for the relief of pain linked to conditions such as muscular aches, toothache, and menstrual cramps.

---

Цитропак is a combination medication used to assist in the temporary management of mild to moderate pain. The formulation, which typically contains acetaminophen, aspirin, and caffeine, is recognized as a therapeutic option for providing relief from various discomforts. The medication is commonly used to help alleviate pain associated with tension headaches and is also recognized for its utility in managing acute migraine headache attacks.

Furthermore, the combination is utilized to address temporary pain from general conditions, including muscular aches, toothache, and menstrual discomfort. The aspirin component may also be recommended in some therapeutic contexts to help reduce the risk of certain cardiovascular events, but this is managed under the direct guidance of a healthcare professional.

Who Can and Cannot Use Цитропак? - Official Regulatory Information

Eligibility for using Цитропак (Acetaminophen, Acetylsalicylic Acid, and Caffeine) is strictly defined by government regulatory documents, focusing on absolute contraindications and population-specific restrictions.

Contraindicated Populations (Must Not Use)

Category	Contraindication Entity
Allergy	History of allergic reaction to acetaminophen, aspirin, or any NSAID.
Co-Medication	Current use of any other drug containing acetaminophen.
Pregnancy	Patients in the last three months (third trimester) of pregnancy.
Pediatric	Children and teenagers with or recovering from chickenpox or flu-like symptoms (Reye's syndrome risk).

---

Age and Condition Restrictions

Population/Condition	Eligibility Status
Adults (18+ years)	Approved for standard use.
Pediatric (Under 18)	Conditional use; must consult a healthcare professional.
Older Adults (60+ years)	Conditional use due to increased risk of severe stomach bleeding.
Liver Disease	Contraindicated in severe liver disease or with chronic heavy alcohol use.
Gastrointestinal	Conditional use with history of stomach ulcers or bleeding problems.

---

Pregnancy and Lactation: Use during pregnancy or while breastfeeding requires consultation with a health professional. Safety and efficacy have not been established for children under 12 years of age.

The official regulatory profile for Цитропак (Acetaminophen, Acetylsalicylic Acid, Caffeine) establishes several mandatory restrictions based on documented pharmacodynamic and pharmacokinetic interactions.

Contraindicated Combinations and Major Restrictions

The product is formally contraindicated for co-administration with any other medication containing acetaminophen due to the severe, dose-related risk of liver damage (hepatotoxicity). Co-use with Monoamine Oxidase Inhibitors (MAOIs) or Methotrexate is also prohibited according to regulatory labels. Furthermore, the label restricts co-administration with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) or salicylates due to the heightened risk of gastrointestinal side effects.

Interactions Affecting Exposure and Bleeding Risk

Co-administration with anticoagulants such as Warfarin carries a significantly increased risk of bleeding because the Acetylsalicylic Acid component has antiplatelet effects, and the Acetaminophen component may enhance the anticoagulant's activity. Substances that inhibit the CYP1A2 enzyme, such as Ciprofloxacin, are documented to increase the systemic exposure and effect of the Caffeine component. Additionally, heavy, chronic alcohol consumption significantly increases the risk of severe liver damage when combined with the acetaminophen component.

Population and Timing Notes

Patients with pre-existing hepatic impairment or a history of alcohol use are identified as having a heightened risk of interaction severity. To manage the potential for drug accumulation and toxicity, the label dictates that doses must be separated by no less than six hours.

Mechanism of Action: How Цитропак Works

Цитропак operates through the combined pharmacodynamic actions of its three components: Paracetamol, Propyphenazone, and Caffeine.

Paracetamol selectively inhibits cyclooxygenase ( COX) isoforms, primarily within the central nervous system. This interaction leads to a reduced synthesis of central prostaglandins ( PGE2), thereby modulating the set-point of the thermoregulatory center located in the hypothalamus.

Propyphenazone, a pyrazolone derivative, exerts an inhibitory effect on both COX-1 and COX-2 activities, resulting in a decreased peripheral generation of biochemical mediators.

Caffeine acts as a non-selective antagonist of adenosine receptors ( A1, A2 A, A2 B), which increases the activity of cyclic adenosine monophosphate ( cAMP) within the central nervous system and mediates a reduction in central neuronal excitability. The combination provides a synergistic interaction at the molecular level, influencing both prostaglandin synthesis and central neural modulation.

How to Use Цитропак

Цитропак (Acetaminophen, Acetylsalicylic Acid, and Caffeine combination) is administered according to a specific regimen. The primary method of delivery is the oral route, typically provided as a 250 mg/250 mg/65 mg strength tablet, caplet, or geltab.

---

Standard Administration Protocol

Instruction	Detail
Route of administration	Oral, intended to be swallowed.
Standard Single Dose	2 tablets, providing 500 mg Acetaminophen, 500 mg Aspirin, and 130 mg Caffeine.
Frequency	The dose may be repeated every 6 hours as needed for symptoms.
Maximum Daily Dose	8 tablets in a 24-hour period.

---

Procedural Instructions and Use Constraints

The medication must be taken with a full glass of water, and users are advised to remain upright for 30 minutes after administration to prevent irritation.

Use is approved for individuals 12 years of age and older. Use in children under 12 years must be under the direction of a healthcare professional.

Usage of this combination is time-limited in the self-treatment context. It should not be used for pain relief for more than 10 days or for fever reduction for more than 3 days. Additionally, this product must not be taken concurrently with other medications containing acetaminophen, and intake of other caffeine sources should be limited.

These instructions define the standardized approach to using the medicine, specifying the route, dose, frequency, and duration limits.

Research evidence / Overview of Studies for Цитропак

Research exploring this combination was evaluated in contexts related to acute migraine headache and has largely involved short-term, randomized controlled trials (RCTs) and systematic reviews. These studies monitored outcomes related to physical discomfort, including measuring the proportion of adults who reported a pain-free state or a reduction in pain intensity within a specific, short time frame, usually two hours. Findings describe patterns observed in the studies related to a pain-free response and outcomes reflecting daily functioning compared to placebo.

This combination was also evaluated in studies related to episodic tension-type headaches. The evidence primarily comes from meta-analyses that explored how symptoms evolved in observed populations during comparisons with placebo and acetaminophen monotherapy. Studies monitored outcomes such as the proportion of episodes where patients were pain-free at the two-hour mark and the degree of interference with daily activities.

Follow-up and Research Gaps

The majority of research for this combination focuses on acute symptom changes. The studies observed responses over defined time intervals immediately following a single dose, typically up to six hours. Because the research focused on treating a single episode, long-term effects are not fully established, and there is limited information regarding use for chronic pain conditions or preventative management.

Research for certain groups remains insufficient. For instance, there is limited information available from specific clinical trials that have explored this combination in children or younger adolescents. Furthermore, comparative evidence is lacking for many general minor pain indications (such as muscular aches or toothache), as findings are often extrapolated from the established research base of the individual components.

Key Studies & References

1. Acetaminophen, aspirin, and caffeine fixed-dose combination
2. Caffeine for the prevention of headache and migraine in adults

Common questions about Цитропак (FAQ)

---

Q: Через сколько времени начинает действовать Цитропак?

Clinical research examines the effectiveness of this combination in short intervals, with relief commonly assessed starting within one to two hours of administration for acute pain. The caffeine component is included as an adjuvant (helper) and is understood to contribute to the combined pain-relieving action.

Q: Что делать, если пропустил приём Цитропака?

According to official guidance, this product is generally used as needed for symptoms, rather than on a strict scheduled regimen. If you miss a dose and it is almost time for the next one, the recommendation is generally to skip the dose. It is important not to take two doses at one time to avoid exceeding the maximum daily limits.

Q: Правда ли, что Цитропак помогает от [неосновное, но популярное показание]?

Official product labeling specifies that this combination is indicated for the temporary relief of minor aches and pains. This includes pain associated with headache, cold, arthritis, muscular aches, toothache, and menstrual cramps. The general purpose is defined as providing symptomatic relief for mild to moderate pain.

Q: Какие анализы нужно сдавать перед приёмом Цитропака?

Regulatory documents do not mandate specific tests for short-term, temporary use of this product. However, if the medication is used regularly for a long time or at high doses, official notes indicate that medical professionals may recommend monitoring laboratory tests, such as those for liver and kidney function, due to the components involved.

Q: Влияет ли Цитропак на давление?

The official labeling indicates that individuals with a history of high blood pressure or heart disease should discuss use with a healthcare professional before starting the product. This is because the caffeine component is associated with an increase in heart rate and may affect blood pressure.

Q: Нужно ли принимать Цитропак строго до или после еды?

This medication can typically be taken with or without food. If the combination causes stomach upset or irritation, regulatory documents note that taking the product with food or milk may help mitigate those effects. Users are also advised to take the tablet with a full glass of water.

Q: Что делать, если при приёме Цитропака появилась тошнота?

Nausea and stomach upset are listed in official documents as common adverse reactions, especially at the start of treatment. If you experience these side effects and they are persistent or bothersome, seeking professional consultation is generally advised.

Q: Влияет ли Цитропак на зрение?

While changes in vision are not listed as common side effects, the official safety information emphasizes symptoms that require immediate attention. Serious eye symptoms, such as sudden vision loss, blurred vision, or eye pain, are listed among the signs that indicate the need for immediate medical attention.

Q: Можно ли принимать Цитропак, если у меня диабет?

The official regulatory label indicates that individuals with diabetes or those taking prescription drugs for the condition should discuss the use of this product with a healthcare professional or pharmacist. This caution relates to the caffeine component, which can potentially affect blood sugar levels.

Q: Может ли Цитропак быть причиной изменений веса?

Weight changes are not classified as a common adverse effect. However, official safety documentation notes that unusual weight gain or swelling should be reported to a healthcare professional, as these symptoms could potentially indicate a more serious underlying condition.

Q: Что делать при передозировке Цитропаком?

If you suspect an overdose, contacting a poison control center or emergency room at once is required. Immediate medical attention is strongly emphasized, even if there are no noticeable symptoms, as the full toxic effects may be delayed for several days.

Q: Цитропак — это рецептурный препарат или можно купить без рецепта?

In many jurisdictions, this product is classified as a non-prescription (OTC) analgesic. It is approved for sale without a prescription for self-medication and the temporary relief of mild to moderate pain.

The official regulatory requirements for storing and disposing of Цитропак (Acetaminophen, Acetylsalicylic Acid, and Caffeine combination) are outlined to maintain product quality and safety.

---

Official Storage Requirements

Requirement	Classification
Storage Temperature	Controlled Room Temperature (e.g., 20 C to 25 C / 68 F to 77 F).
Environmental Protection	Must be protected from moisture (humidity) and excessive heat.
Container Rule	Must be stored in the original container and kept tightly closed.
Shelf-Life	Do not use after the expiration date printed on the package.
Child Protection	Must be kept out of the sight and reach of children.

---

Disposal Instructions

Disposal must be conducted according to local regulations or via an authorized drug take-back program. The product should not be flushed down a toilet or drain (wastewater disposal) unless specifically instructed by regulatory authorities or the product label. Following these instructions is required for appropriate pharmaceutical waste management.